Allergy/Imm Medical News about DTaP

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Novel therapies for children with severe asthma

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Immunogenicity and safety of a combined DTaP–IPV vaccine compared with separate DTaP and IPV vaccines when administered as pre-school booster doses with a second dose of MMR vaccine to healthy children aged 4–6 years
Vaccine , 09/01/06

Steven Black, et al. - This combined DTaP–IPV appeared safe and immunogenic when given as a booster dose at 4–6 years of age. The DTaP–IPV vaccine had no negative effect on the response to co-administered MMR vaccine, making it well-suited for use as a pre-school booster

<< Previous
Analysis of human sera that are polyreactive in an addressable...

Next >>
Modeling of tumor necrosis factor receptor superfamily 1A mutants...